Page last updated: 2024-08-24

phosphoramidic acid and Cancer of Prostate

phosphoramidic acid has been researched along with Cancer of Prostate in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (18.18)	29.6817
2010's	8 (72.73)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Heston, WDW; Huang, SS	1
Anderson, CJ; Berkman, CE; Beyer, SK; Choy, CJ; Geruntho, JJ; Langton-Webster, B; Latoche, JD; Ling, X	1
Ciarmiello, A; Duce, V; Giovacchini, G; Giovannini, E; Pastorino, S; Riondato, M; Uccelli, L	1
Beattie, NR; Berkman, CE; Dannoon, S; Ley, CR; Regan, M; VanBrocklin, H	1
Barinka, C; Berkman, CE; Blecha, JE; Cahaya, H; Dannoon, S; Drake, CR; Ganguly, T; Hopkins, MR; Jivan, S; Jones, EF; Murphy, S; VanBrocklin, HF	1
Anderson, CJ; Berkman, CE; Day, KE; Ganguly, T; Kurland, BF; Latoche, JD; Modi, J; Nedrow, JR; Zeng, D	1
Barinka, C; Berkman, CE; Beyer, SK; Blecha, JE; Cahaya, H; Choy, CJ; Dannoon, S; Drake, CR; Galliher, MS; Ganguly, T; Geruntho, JJ; Hopkins, MR; Jivan, S; Jones, EF; Regan, M; Skultetyova, L; VanBrocklin, HF	1
Berkman, CE; Jones, EF; Lapi, SE; Liu, T; Nedrow-Byers, JR; Pham, D; VanBrocklin, HF; Vejdani, K; Wahnishe, H; Wu, LY	1
Aiba, Y; Beigelman, L; Blatt, L; Leisvuori, A; Lönnberg, H; Lönnberg, T; Poijärvi-Virta, P	1
Benny, P; Berkman, CE; Bryan, JN; Ganguly, T; He, H; Jabbes, M; Jewett, C; Liu, T; Nedrow-Byers, JR	1
Berkman, CE; Kazak, M; Liu, T; Wu, LY	1

Reviews

1 review(s) available for phosphoramidic acid and Cancer of Prostate

Article	Year
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications. Current radiopharmaceuticals, 2020, Volume: 13, Issue:1 Topics: Amides; Antibodies, Monoclonal; Aptamers, Nucleotide; Drug Development; Drug Discovery; Glutamates; Humans; Immunoglobulin Fragments; Kallikreins; Male; Nuclear Medicine; Organophosphonates; Phosphoric Acids; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Sulfhydryl Compounds; Urea	2020

Article

Year

Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications.

Current radiopharmaceuticals, 2020, Volume: 13, Issue:1

Topics: Amides; Antibodies, Monoclonal; Aptamers, Nucleotide; Drug Development; Drug Discovery; Glutamates; Humans; Immunoglobulin Fragments; Kallikreins; Male; Nuclear Medicine; Organophosphonates; Phosphoric Acids; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Sulfhydryl Compounds; Urea

2020

Other Studies

10 other study(ies) available for phosphoramidic acid and Cancer of Prostate

Article	Year
Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting? Theranostics, 2017, Volume: 7, Issue:7 Topics: Albumins; Amides; Animals; Antigens, Surface; Glutamate Carboxypeptidase II; Humans; Ligands; Male; Mice; Molecular Weight; Phosphoric Acids; Prostatic Neoplasms; Tissue Distribution	2017
Theranostics, 2017, Volume: 7, Issue:7 Topics: Albumins; Amides; Animals; Antigens, Surface; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Glutamate Carboxypeptidase II; Heterografts; Humans; Lutetium; Male; Mice; Mice, Nude; Phosphoric Acids; Prostatic Neoplasms; Radioisotopes; Treatment Outcome	2017
Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen. Bioorganic & medicinal chemistry letters, 2015, Jun-15, Volume: 25, Issue:12 Topics: Amides; Animals; Antigens, Surface; Cell Line, Tumor; Contrast Media; Drug Evaluation, Preclinical; Glutamate Carboxypeptidase II; Humans; Male; Mice; Mice, Nude; Phosphoric Acids; Positron-Emission Tomography; Prostatic Neoplasms; Protein Binding; Radiopharmaceuticals; Tomography, X-Ray Computed; Transplantation, Heterologous	2015
A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. Nuclear medicine and biology, 2015, Volume: 42, Issue:10 Topics: Amides; Animals; Antigens, Surface; Biological Transport; Cell Line, Tumor; Drug Stability; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Humans; Inhibitory Concentration 50; Isotope Labeling; Male; Mice; Models, Molecular; Peptidomimetics; Phosphoric Acids; Positron-Emission Tomography; Prostatic Neoplasms; Protease Inhibitors; Protein Conformation; Tissue Distribution	2015
Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer. Molecular imaging and biology, 2016, Volume: 18, Issue:3 Topics: Amides; Animals; Blotting, Western; Copper Radioisotopes; Endocytosis; Male; Mice, Nude; Phosphoric Acids; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays	2016
Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer. Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12 Topics: Amides; Animals; Antigens, Surface; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Peptidomimetics; Phosphoric Acids; Positron-Emission Tomography; Prostatic Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured	2016
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:12 Topics: Amides; Animals; Antigens, Surface; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Humans; Isotope Labeling; Male; Mice; Peptides; Phosphoric Acids; Positron-Emission Tomography; Prostatic Neoplasms; Tissue Distribution	2009
Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5'-monophosphates bearing a biodegradable protecting group. Organic & biomolecular chemistry, 2010, May-07, Volume: 8, Issue:9 Topics: Acetates; Alanine; Amides; Animals; Antiviral Agents; Cytidine Monophosphate; Enzyme Stability; Esterases; Humans; Kinetics; Liver; Male; Malonates; Molecular Structure; Phosphoric Acids; Prostatic Neoplasms; Ribavirin; Swine; Time Factors	2010
A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent. The Prostate, 2012, Jun-01, Volume: 72, Issue:8 Topics: Adenocarcinoma; Amides; Animals; Cell Line, Tumor; Humans; In Vitro Techniques; Male; Mice; Mice, Nude; Pentetic Acid; Phosphoric Acids; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Technetium; Time Factors; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous	2012
Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen. The Prostate, 2008, Jun-15, Volume: 68, Issue:9 Topics: Amides; Antigens, Surface; Binding, Competitive; Cell Line, Tumor; Fluorescent Dyes; Glutamate Carboxypeptidase II; Humans; Inhibitory Concentration 50; Male; Microscopy, Fluorescence; Phosphoric Acids; Prostatic Neoplasms; Rhodamines; Xanthenes	2008